Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Fludarabine in Previously Untreated B-Cell CLL
NCT00049075Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Aug 2002
- Primary completion
- Jul 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of fludarabine in chronic lymphocytic leukemia (CLL), sponsored by Canadian Cancer Trials Group. Started Aug 2002; status: completed.
02
Drugs
fludarabine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00049075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049075.